CHARLESTON, WV (WVNS) – Online gaming platform Roblox has become the subject of an ongoing investigation amid privacy and safety concerns. Collaborative chat features within Roblox have raised ...

Roblox stock has more than tripled in a year, thanks to strong business results. Management still has a massive growth opportunity ahead of it. If the company can achieve its goals, the current ...

Update: We've updated this page with additional links to our guides on how to complete various The Hunt: Mega Edition quests in Roblox, and have added some further detail on Mega Tokens and how to get ...

Advertising is Roblox’s biggest profitability lever. Older users already make up most of Roblox’s daily active users, and retaining them as they spend more could dramatically improve monetization.

Dabo Swinney's press conferences this season -- much like his Clemson Tigers' season as a whole -- have been a roller coaster. Now, with the preseason No. 4 team sitting at 1-3, he's taking ...

Clemson coach Dabo Swinney delivered a rare, blunt assessment of his struggling Tigers during his weekly press conference ahead of Saturday’s matchup with North Carolina. The Clemson program, long ...

Medtech startup Axon Therapies has raised $32 million from investors to ramp up clinical trials for a new instrument to treat heart failure, the company announced. The Series A fundraise, led by ...

Clemson coach Dabo Swinney delivered a rare, blunt assessment of his struggling Tigers during his weekly press conference ahead of Saturday’s matchup with North Carolina. The Clemson program, long ...

Dabo Swinney spent Clemson’s off week examining how his team has started the season 1-3. After beginning the 2025 season in the top 10 of the AP Top 25, Clemson lost to LSU and has lost to Georgia ...

CLEMSON, S.C. — Coming out of an off week after a disappointing 1-3 start — the worst of Dabo Swinney’s 18 seasons as Clemson head coach — Swinney described his team’s early struggles as “a coaching ...

Clemson Tigers head coach Dabo Swinney hasn’t had the start to the season that he’s wished for, being 1-3 for the first time in his tenure with the program. When speaking to the media on Tuesday ...

CytomX Therapeutics pivots to focus on CX-2051 for metastatic colorectal cancer after terminating prior clinical candidates and restructuring operations. CX-2051 shows promising early Phase 1 efficacy ...